A research team affiliated with UNIST has unveiled an innovative, cost-effective biosensor capable of being washed and reused, paving the way for more accessible liquid biopsy diagnostics. This new ...

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection. A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by ...

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK and Europe: the GridION™ Dx. OXFORD, England--(BUSINESS WIRE)-- ...

Five companies, including LEAP India and Eldorado Agritech, have received SEBI's approval for IPOs. Others include Molbio Diagnostics, Foodlink F&B Holdings, and Technocraft Ventures. Meanwhile, Inox ...

KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (BGLC) ("BGLC" or the "Company"), a biotechnology company advancing precision diagnostics and gene-based technologies, ...

Exosomes Europe 2025 (4–5 November; Amsterdam, Netherlands) brought together key opinion leaders in the exosome space to discuss the progress and roadblocks in exosome production, applications and ...